MBD | BI-RADS | |||||
---|---|---|---|---|---|---|
n (%) | ORcru (95% CI)a | ORadj (95% CI)b | n (%) | ORcru (95% CI)a | ORadj (95% CI)b | |
Physical activity | ||||||
MET-hours/week | ||||||
Low (< 28.5) | 552 (54) | 1.00 (REF) | 1.00 (REF) | 203 (55) | 1.00 (REF) | 1.00 (REF) |
High (≥ 28.5) | 470 (46) | 1.18 (0.91–1.53) | 1.05 (0.79–1.40) | 164 (45) | 1.08 (0.71–1.65) | 1.05 (0.66–1.65) |
Continuous | 1022 (100) | 1.00 (1.00*-1.01) | 1.00 (1.00*-1.01) | 367 (100) | 1.00 (1.00*-1.01) | 1.00 (1.00*-1.01) |
WHO guidelines | ||||||
Subceed | 116 (11) | 1.00 (REF) | 1.00 (REF) | 54 (15) | 1.00 (REF) | 1.00 (REF) |
Adhere | 224 (22) | 0.94 (0.58–1.55) | 0.96 (0.56–1.64) | 77 (21) | 1.21 (0.58–2.51) | 1.15 (0.52–2.50) |
Exceed | 682 (67) | 1.40 (0.91–2.14) | 1.24 (0.78–1.98) | 236 (64) | 1.45 (0.78–2.69) | 1.40 (0.72–2.72) |
p-trend | 0.023 | 0.176 | 0.215 | 0.269 | ||
Moderate intensity | ||||||
< 150 min | 189 (19) | 1.00 (REF) | 1.00 (REF) | 78 (21) | 1.00 (REF) | 1.00 (REF) |
150–300 min | 307 (30) | 1.14 (0.75–1.65) | 1.18 (0.77–1.81) | 111 (31) | 1.19 (0.65–2.18) | 1.30 (0.68–2.49) |
≥ 300 min | 513 (51) | 1.40 (0.98–2.00) | 1.36 (0.92–2.01) | 174 (48) | 1.43 (0.82–2.49) | 1.43 (0.80–2.58) |
p-trend | 0.043 | 0.110 | 0.191 | 0.245 | ||
Vigorous intensity | ||||||
< 75 min | 510 (67) | 1.00 (REF) | 1.00 (REF) | 192 (68) | 1.00 (REF) | 1.00 (REF) |
75–150 min | 173 (23) | 1.17 (0.81–1.67) | 1.20 (0.80–1.78) | 65 (23) | 0.93 (0.52–1.67) | 1.01 (0.54–1.89) |
≥ 150 min | 78 (10) | 1.42 (0.87–2.31) | 1.28 (0.75–2.20) | 27 (10) | 1.28 (0.57–2.88) | 1.25 (0.49–3.14) |
p-trend | 0.132 | 0.260 | 0.724 | 0.710 |